Lexicon Pharmaceuticals, Inc. (LXRX) Capital expenditures 2016–2025
Lexicon Pharmaceuticals, Inc. (LXRX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$0FY2025 · since FY2016: $231,000 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $0 | -100.0% |
| FY2024 | $1.0M | +119.4% |
| FY2023 | $470,000 | -64.6% |
| FY2022 | $1.3M | +8.6% |
| FY2021 | $1.2M | +1303.4% |
| FY2020 | $87,000 | +24.3% |
| FY2019 | $70,000 | -26.3% |
| FY2018 | $95,000 | -58.3% |
| FY2017 | $228,000 | -1.3% |
| FY2016 | $231,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice